AstraZeneca Reports Positive Results from New Breast Cancer Treatment Trial
Drug researchers from AstraZeneca PLC have reported that results from the late-stage trials of their drug Enhertu have been shown to improve the survival rates of their breast cancer patients. Enhertu is the latest of a series of drugs developed